BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17671688)

  • 1. Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene.
    Müller-Brüsselbach S; Ebrahimsade S; Jäkel J; Eckhardt J; Rapp UR; Peters JM; Moll R; Müller R
    Int J Oncol; 2007 Sep; 31(3):607-11. PubMed ID: 17671688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profile of mouse fibroblasts with a targeted disruption of the peroxisome proliferator activated receptor-beta/delta gene.
    Adamkiewicz J; Kaddatz K; Rieck M; Wilke B; Müller-Brüsselbach S; Müller R
    Proteomics; 2007 Apr; 7(8):1208-16. PubMed ID: 17380536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
    Götz R; Kramer BW; Camarero G; Rapp UR
    BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis.
    Sato K; Yonemura T; Ishii H; Toyomizu M; Kamada T; Akiba Y
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Nov; 154(3):370-5. PubMed ID: 19619666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.
    Kerkhoff E; Fedorov LM; Siefken R; Walter AO; Papadopoulos T; Rapp UR
    Cell Growth Differ; 2000 Apr; 11(4):185-90. PubMed ID: 10775035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
    Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
    Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
    Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
    J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
    Ritzenthaler JD; Roman J; Han S
    Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
    Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.
    Burdick AD; Kim DJ; Peraza MA; Gonzalez FJ; Peters JM
    Cell Signal; 2006 Jan; 18(1):9-20. PubMed ID: 16109478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes.
    Tsuji K; Mitsutake S; Yokose U; Sugiura M; Kohama T; Igarashi Y
    FEBS J; 2008 Aug; 275(15):3815-26. PubMed ID: 18565104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARbeta/delta ligands as modulators of the inflammatory response.
    Kilgore KS; Billin AN
    Curr Opin Investig Drugs; 2008 May; 9(5):463-9. PubMed ID: 18465655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
    Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
    J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.